Funding for this research was provided by:
Canadian Institutes of Health Research (500298)
Received: 5 May 2020
Accepted: 19 July 2021
First Online: 29 July 2021
: This study and related protocols were approved by the University of Toronto HIV Research Ethics Board. Informed verbal consent was obtained from all individual participants included in the study. Verbal consent was used to help protect the confidentiality of participants and in order to reduce ethical risks for PLHIV who use drugs. Participants were asked to provide verbal consent and the interviewer signed as witness of verbal consent. The ethics board approved this procedure.
: Not applicable.
: The authors declare that they have no competing interests